AmgenvsIntegra LifeSciences

AMGN and IART stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$437.33

Value $236B

-1.53%
AMGN's page

IART

Integra LifeSciences Holdings Corporation

$13.63

Value $1.1B

-1.66%
IART's page

Amgen (AMGN) has a market value of $236B and Integra LifeSciences (IART) $1.1B. Over the last year, with dividends, AMGN moved +30.5% and IART +19.4%. The P/E is 25.1 for AMGN and 81.6 for IART. Dividend yield: AMGN 2.27%, IART none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$236B

    IART$1.1B

    AMGN is 222 times IART

  • Revenue, 12 months

    AMGN$38.9B

    IART$1.7B

    AMGN is 23 times IART

  • Net income, 12 months

    AMGN$9.4B

    IART$13M

    AMGN is 722 times IART

  • Operating margin

    AMGN32.4%

    IART4.4%

    28.0 points apart

  • ROIC

    AMGN16.2%

    IART2.7%

    13.5 points apart

  • P/E

    AMGN25.1

    IART81.6

    IART is 3.3 times AMGN

  • Dividend yield

    AMGN2.3%

    IART0.0%

    2.3 points apart

  • 5-year return

    AMGN+148.1%

    IART-79.9%

    228.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+148.1%

IART-79.9%

010020020222023202420252026
Returns by period
PeriodAMGNWith dividendsIARTWith dividends
1 year since November 18, 2025+30.5%Price +27.0%+19.4%Price +19.4%
3 years since November 17, 2023+78.7%+21.4% a yearPrice +64.6%-64.8%-29.4% a yearPrice -64.8%
5 years since November 18, 2021+148.1%+19.9% a yearPrice +114.2%-79.9%-27.5% a yearPrice -79.9%
10 years since November 21, 2016+301.5%+14.9% a yearPrice +200.2%-66.9%-10.5% a yearPrice -66.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenIARTIntegra LifeSciences

Valuation

AMGNIART
Valuation
Price$437.33$13.63
Market value$236B$1.1B
Enterprise value (EV)$277B–
P/E25.181.6
P/E, 5-year median23.033.8
P/B16.41.0
EV/EBIT21.9–
Free cash flow yield4.1%8.1%

Results and growth

AMGNIART
Results and growth
Revenue, 12 months$38.9B$1.7B
Net income, 12 months$9.4B$13M
Free cash flow, 12 months$9.6B$86M
Earnings per share, 12 months$17.25$0.17
Revenue growth, year on year10.0%1.5%
Revenue growth a year, past+7.6%over 5 years+3.6%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNIART
Margins and returns on capital
Gross margin70.9%52.4%
Operating margin32.4%4.4%
Net margin24.1%0.8%
ROIC16.2%2.7%
ROE87.8%1.2%

Balance sheet

AMGNIART
Balance sheet
Cash$13.2B$312M
Total debt$54.0B–
Net debt / EBITDA2.3–
Interest cover4.8×0.8×

Dividends and buybacks

AMGNIART
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.0%
Shareholder yield2.3%0.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or IART

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Integra LifeSciences?

By market value, Amgen ($236B) is about 221.9 times Integra LifeSciences ($1.1B), at today's prices.

How did AMGN and IART stock do over the last 10 years?

Since November 21, 2016, AMGN's price moved +200.2% and IART's -66.9%. With dividends: AMGN +301.5% (+14.9% a year), IART -66.9% (-10.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or IART?

The dividend yield at today's price is 2.27% for Amgen and none for Integra LifeSciences. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and IART?

At today's price, the P/E is 25.1 for AMGN and 81.6 for IART. The median of the last five years was 23.0 and 33.8, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Integra LifeSciences?

Over the last twelve months, the net margin was 24.1% for Amgen and 0.8% for Integra LifeSciences, and the operating margin 32.4% and 4.4%. Revenue was $38.9B and $1.7B.

Which is the better investment, Amgen or Integra LifeSciences?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.